Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Change in Accured Expenses (2020 - 2026)

Surrozen (SRZN) posted quarterly Change in Accured Expenses of -$1.2 million for Q1 2026, up 2.51% year-over-year from -$1.1 million in Q1 2025, and down 139.6% quarter-over-quarter from $2.9 million in Q4 2025.

Analysis

Surrozen (SRZN) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Surrozen's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$1.2 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses rose 2.51% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at $2.5 million (up 152.54% YoY), while the FY2025 annual figure was $2.5 million, up 137.03% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$1.2 million, down from $2.9 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.9 million in Q4 2025, with the low at -$3.8 million in Q1 2022.
  • The 5-year median for Change in Accured Expenses is $178000.0 (2023), against an average of -$113882.4.
  • The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses sank 310.11% in 2022, then soared 810.81% in 2024.
  • Surrozen's Change in Accured Expenses stood at $651000.0 in 2022, then tumbled by 72.66% to $178000.0 in 2023, then surged by 385.39% to $864000.0 in 2024, then jumped by 239.93% to $2.9 million in 2025, then plunged by 139.6% to -$1.2 million in 2026.
  • Business Quant data shows SRZN's Change in Accured Expenses at -$1.2 million in Q1 2026, $2.9 million in Q4 2025, and $555000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Surrozen 263.35 Mn 263.35 Mn - -799,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -799,000.00
Mar 31, 2026 -1.16 Mn
Dec 31, 2025 2.94 Mn
Sep 30, 2025 555,000.00
Jun 30, 2025 204,000.00
Mar 31, 2025 -1.19 Mn
Dec 31, 2024 864,000.00
Sep 30, 2024 674,000.00
Jun 30, 2024 658,000.00
Mar 31, 2024 -1.14 Mn
Dec 31, 2023 178,000.00
Sep 30, 2023 74,000.00
Jun 30, 2023 -1.42 Mn
Mar 31, 2023 -1.39 Mn
Dec 31, 2022 651,000.00
Sep 30, 2022 157,000.00
Jun 30, 2022 1.19 Mn
Mar 31, 2022 -3.78 Mn
Dec 31, 2021 669,000.00
Sep 30, 2021 875,000.00